Neurosense Therapeutics Ltd Stock Price History
| NRSNW Stock | USD 0.21 0.01 5.00% |
If you're considering investing in NeuroSense Stock, it is important to understand the factors that can impact its price. As of today, the current price of NeuroSense Therapeutics stands at 0.21, as last reported on the 5th of March, with the highest price reaching 0.22 and the lowest price hitting 0.19 during the day. NeuroSense Therapeutics is out of control given 3 months investment horizon. NeuroSense Therapeutics has Sharpe Ratio of 0.0954, which conveys that the firm had a 0.0954 % return per unit of risk over the last 3 months. We were able to interpolate twenty-eight different technical indicators, which can help you to evaluate if expected returns of 2.55% are justified by taking the suggested risk. Use NeuroSense Therapeutics Downside Deviation of 28.62, mean deviation of 22.83, and Risk Adjusted Performance of 0.1205 to evaluate company specific risk that cannot be diversified away.
At this time, NeuroSense Therapeutics' Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 5.3 M in 2025, whereas Other Stockholder Equity is likely to drop slightly above 18 M in 2025. . Price Earnings Ratio is likely to drop to -1 in 2025. Price Book Value Ratio is likely to climb to -6.24 in 2025. NeuroSense Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
NeuroSense |
Sharpe Ratio = 0.0954
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | NRSNW | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 26.74 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.55 actual daily | 50 50% of assets have lower returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average NeuroSense Therapeutics is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NeuroSense Therapeutics by adding it to a well-diversified portfolio.
Book Value (0.14) | Shares Float 9.6 M | Shares Short Prior Month 220 | Earnings Share (0.94) | Shares Short 184 |
NeuroSense Therapeutics Stock Price History Chart
There are several ways to analyze NeuroSense Stock price data. The simplest method is using a basic NeuroSense candlestick price chart, which shows NeuroSense Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 15, 2025 | 0.53 |
| Lowest Price | November 22, 2024 | 0.15 |
NeuroSense Therapeutics March 5, 2025 Stock Price Synopsis
Various analyses of NeuroSense Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell NeuroSense Stock. It can be used to describe the percentage change in the price of NeuroSense Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of NeuroSense Stock.| NeuroSense Therapeutics Price Rate Of Daily Change | 1.05 | |
| NeuroSense Therapeutics Price Action Indicator | 0.01 | |
| NeuroSense Therapeutics Accumulation Distribution | 1,192 | |
| NeuroSense Therapeutics Price Daily Balance Of Power | 0.33 |
NeuroSense Therapeutics March 5, 2025 Stock Price Analysis
NeuroSense Stock Price History Data
The price series of NeuroSense Therapeutics for the period between Thu, Dec 5, 2024 and Wed, Mar 5, 2025 has a statistical range of 0.41 with a coefficient of variation of 35.55. The daily prices for the period are spread out with arithmetic mean of 0.3. The median price for the last 90 days is 0.26.| Open | High | Low | Close | Volume | ||
| 03/04/2025 | 0.19 | 0.22 | 0.19 | 0.21 | 8,740 | |
| 03/03/2025 | 0.15 | 0.21 | 0.15 | 0.21 | 953.00 | |
| 02/28/2025 | 0.20 | 0.22 | 0.17 | 0.20 | 12,721 | |
| 02/27/2025 | 0.24 | 0.40 | 0.17 | 0.22 | 83,857 | |
| 02/26/2025 | 0.32 | 0.32 | 0.23 | 0.27 | 15,054 | |
| 02/25/2025 | 0.24 | 0.65 | 0.20 | 0.33 | 559,570 | |
| 02/24/2025 | 0.23 | 0.24 | 0.20 | 0.20 | 2,664 | |
| 02/21/2025 | 0.24 | 0.24 | 0.24 | 0.24 | 300.00 | |
| 02/20/2025 | 0.30 | 0.32 | 0.23 | 0.24 | 300.00 | |
| 02/19/2025 | 0.30 | 0.30 | 0.30 | 0.30 | 1,100 | |
| 02/18/2025 | 0.20 | 0.20 | 0.20 | 0.20 | 306.00 | |
| 02/14/2025 | 0.30 | 0.30 | 0.23 | 0.23 | 934.00 | |
| 02/13/2025 | 0.31 | 0.31 | 0.25 | 0.29 | 1,362 | |
| 02/12/2025 | 0.28 | 0.28 | 0.23 | 0.23 | 1,233 | |
| 02/11/2025 | 0.21 | 0.21 | 0.20 | 0.20 | 1,030 | |
| 02/10/2025 | 0.32 | 0.32 | 0.24 | 0.24 | 1,211 | |
| 02/07/2025 | 0.20 | 0.50 | 0.20 | 0.20 | 1,386 | |
| 02/06/2025 | 0.22 | 0.24 | 0.21 | 0.23 | 3,051 | |
| 02/05/2025 | 0.20 | 0.20 | 0.20 | 0.20 | 110.00 | |
| 02/04/2025 | 0.25 | 0.25 | 0.25 | 0.25 | 800.00 | |
| 02/03/2025 | 0.25 | 0.25 | 0.25 | 0.25 | 550.00 | |
| 01/31/2025 | 0.26 | 0.28 | 0.23 | 0.23 | 1,380 | |
| 01/30/2025 | 0.25 | 0.25 | 0.25 | 0.25 | 766.00 | |
| 01/29/2025 | 0.33 | 0.33 | 0.13 | 0.20 | 2,760 | |
| 01/28/2025 | 0.24 | 0.33 | 0.12 | 0.27 | 6,991 | |
| 01/24/2025 | 0.34 | 0.34 | 0.34 | 0.34 | 1.00 | |
| 01/23/2025 | 0.31 | 0.34 | 0.31 | 0.34 | 140.00 | |
| 01/22/2025 | 0.31 | 0.35 | 0.29 | 0.33 | 2,025 | |
| 01/21/2025 | 0.24 | 0.24 | 0.24 | 0.24 | 357.00 | |
| 01/17/2025 | 0.45 | 0.45 | 0.23 | 0.23 | 6,390 | |
| 01/15/2025 | 0.47 | 0.56 | 0.47 | 0.53 | 3,333 | |
| 01/14/2025 | 0.63 | 1.06 | 0.31 | 0.45 | 4,622 | |
| 01/13/2025 | 0.53 | 0.53 | 0.51 | 0.51 | 276.00 | |
| 01/10/2025 | 0.44 | 0.61 | 0.44 | 0.52 | 9,269 | |
| 01/08/2025 | 0.32 | 0.32 | 0.32 | 0.32 | 19.00 | |
| 01/06/2025 | 0.41 | 0.41 | 0.37 | 0.40 | 4,275 | |
| 01/03/2025 | 0.34 | 0.36 | 0.28 | 0.36 | 7,778 | |
| 01/02/2025 | 0.31 | 0.31 | 0.31 | 0.31 | 569.00 | |
| 12/31/2024 | 0.41 | 0.44 | 0.33 | 0.44 | 4,692 | |
| 12/30/2024 | 0.29 | 0.44 | 0.29 | 0.44 | 1,581 | |
| 12/27/2024 | 0.44 | 0.44 | 0.44 | 0.44 | 1,500 | |
| 12/26/2024 | 0.37 | 0.37 | 0.37 | 0.37 | 100.00 | |
| 12/24/2024 | 0.46 | 0.46 | 0.46 | 0.46 | 1,200 | |
| 12/23/2024 | 0.50 | 0.71 | 0.45 | 0.45 | 17,938 | |
| 12/20/2024 | 0.39 | 0.42 | 0.39 | 0.42 | 1,055 | |
| 12/19/2024 | 0.50 | 0.50 | 0.50 | 0.50 | 21.00 | |
| 12/18/2024 | 0.37 | 0.52 | 0.37 | 0.50 | 4,700 | |
| 12/17/2024 | 0.35 | 0.35 | 0.35 | 0.35 | 511.00 | |
| 12/16/2024 | 0.30 | 0.30 | 0.30 | 0.30 | 910.00 | |
| 12/13/2024 | 0.25 | 0.25 | 0.25 | 0.25 | 411.00 | |
| 12/12/2024 | 0.29 | 0.50 | 0.18 | 0.38 | 14,776 | |
| 12/11/2024 | 0.25 | 0.31 | 0.25 | 0.25 | 528.00 | |
| 12/09/2024 | 0.30 | 0.30 | 0.15 | 0.15 | 424.00 | |
| 12/06/2024 | 0.36 | 0.36 | 0.36 | 0.36 | 15.00 | |
| 12/05/2024 | 0.34 | 0.36 | 0.34 | 0.36 | 476.00 | |
| 12/02/2024 | 0.25 | 0.25 | 0.25 | 0.25 | 677.00 | |
| 11/29/2024 | 0.30 | 0.30 | 0.24 | 0.24 | 1,111 | |
| 11/27/2024 | 0.24 | 0.30 | 0.17 | 0.30 | 3,127 | |
| 11/25/2024 | 0.15 | 0.15 | 0.15 | 0.15 | 33.00 | |
| 11/22/2024 | 0.15 | 0.15 | 0.15 | 0.15 | 600.00 | |
| 11/21/2024 | 0.26 | 0.26 | 0.26 | 0.26 | 324.00 |
About NeuroSense Therapeutics Stock history
NeuroSense Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NeuroSense is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NeuroSense Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NeuroSense Therapeutics stock prices may prove useful in developing a viable investing in NeuroSense Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 15.7 M | 16.5 M |
NeuroSense Therapeutics Stock Technical Analysis
NeuroSense Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
NeuroSense Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NeuroSense Therapeutics' price direction in advance. Along with the technical and fundamental analysis of NeuroSense Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NeuroSense to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1205 | |||
| Jensen Alpha | 4.24 | |||
| Total Risk Alpha | 7.91 | |||
| Sortino Ratio | 0.1569 | |||
| Treynor Ratio | (2.38) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for NeuroSense Stock Analysis
When running NeuroSense Therapeutics' price analysis, check to measure NeuroSense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroSense Therapeutics is operating at the current time. Most of NeuroSense Therapeutics' value examination focuses on studying past and present price action to predict the probability of NeuroSense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroSense Therapeutics' price. Additionally, you may evaluate how the addition of NeuroSense Therapeutics to your portfolios can decrease your overall portfolio volatility.